Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium

Area of Science:

• Gynecology
• Oncology
• Molecular Biology

Background:

• CD24 is a significant biomarker in various female cancers.
• Endometrial cancer diagnosis and prognosis can benefit from understanding CD24 expression patterns.

Purpose of the Study:

• To investigate CD24 expression in normal, hyperplastic, and carcinomatous endometrium.
• To correlate CD24 expression with estrogen receptor (ER) and progesterone receptor (PR) levels.
• To evaluate CD24's potential as a diagnostic marker for endometrial pathologies.

Main Methods:

• Immunohistochemistry was used to analyze CD24, ER, and PR protein expression in 271 endometrial tissue samples.
• RT-PCR was employed to assess CD24 mRNA levels.
• Samples included normal, hyperplastic (simple, complex, atypical), and carcinomatous endometrium.

Main Results:

• CD24 exhibited cyclic expression in normal endometrium, with lower levels in the proliferative phase and higher levels in the secretory phase.
• CD24 expression was weak in atrophic endometrium, reduced in hyperplasias, and significantly elevated in endometrial carcinomas.
• High CD24 expression in carcinomas correlated with higher tumor grade (G2/G3) and showed an inverse relationship with ER and PR expression.

Conclusions:

• CD24 displays a distinct cyclic expression pattern in normal endometrium.
• Increased CD24 expression is associated with endometrial carcinoma development and progression.
• CD24 may serve as a valuable diagnostic biomarker for endometrial cancer.